Global /United States /Healthcare /Medical Devices /ANGO
chevron_leftBack
AngioDynamics, Inc. logo

AngioDynamics, Inc.

ANGO
NASDAQ: ANGO Delayed
10.68USD -2.8%
As of 13 June 2026, AngioDynamics, Inc. has a market cap of $444.96M USD, ranking #15936 globally and #2721 in the United States. It ranks #1425 in the Healthcare sector, and #295 in the Medical Devices industry.
Global Rank
15936
Country Rank
2721
Sector Rank
1425
Industry Rank
295
Key Stats
Market Cap
$444.96MUSD
Enterprise Value
$416.25MUSD
Revenue (TTM)
$313.73MUSD
EBITDA (TTM)
-$659.0KUSD
Net Income (TTM)
-$31.39MUSD
EBITDA Margin
-0.2%
Profit Margin
-10%
PS Ratio
1.4
PB Ratio
2.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
James Clemmer open_in_new
Employees
675
Founded
1988
IPO
27 May 2004
Website
angiodynamics.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.8% -0.1% -1.7% 7% -13% 13%

News

Loading...

ANGO Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
ANGO
AngioDynamics Inc
ISIN: US03475V1017
Shares Out.:
41.319M1 Shares Float: 36.549M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
10.68 USD
Frankfurt Stock Exchange
MIC: XFRA
UG2
AngioDynamics Inc
ISIN: US03475V1017
TV:
SA:
YF:
GF:
BA:
UG2
MS:
8.95 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About AngioDynamics, Inc.

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers’ off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
39K%
25.8
$160.73B
36K%
56.7
$159.07B
36K%
25.6
DHR
$126.55B
28K%
34.7
SYK
$120.69B
27K%
38.3
$84.93B
19K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
23K%
22.2
$97.46B
84.32B EUR
22K%
36.7
7741
$61.41B
9.83T JPY
14K%
40.0
$45.47B
39.34B EUR
10K%
18.7
ALC
$36.38B
28.99B CHF
8K%
37.9
$30.06B
203.66B CNY
7K%
26.0
chevron_leftBack